Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-03-06 Regulatory Filings
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE: Poster presentations at ATTD 2024 in Firenze
Regulatory Filings Classification · 1% confidence The document text is a technical report detailing 'DYNAMIC INTERFERENCE TESTING RESULTS WITH THE LIBRE 3 CONTINUOUS GLUCOSE MONITORING DEVICE IN COMPARISON TO LIBRE 2'. It presents detailed experimental methods, results (including tables and figures showing bias percentages), references to scientific literature, and acknowledgments for research funding. This content structure strongly suggests a scientific or technical paper, likely a research article or a detailed technical report, rather than a standard regulatory filing like a 10-K, ER, or IR. Since there is no specific category for a standalone scientific research paper, and it is not a standard SEC filing, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it represents a formal, non-standard disclosure of technical findings, or potentially 'Audit Report / Information' (AR) if interpreted broadly as a technical assessment, but RNS is a safer general fallback for non-standard disclosures. Given the highly technical, non-financial nature, and the lack of standard SEC headers, RNS is the best fit among the provided options for a formal, published technical document that isn't a core financial report.
2024-03-06 English
LIFE: Poster presentations at ATTD 2024 in Firenze
Regulatory Filings Classification · 1% confidence The document is a scientific research summary or clinical study report regarding a medical device prototype (Sencell). It details methodology, results, and conclusions of a human pilot study. It does not contain financial statements, regulatory filings, or corporate governance information. As it is a technical research paper/abstract and does not fit into any of the specific financial filing categories provided, it falls under the 'Regulatory Filings' (RNS) category as the designated fallback for miscellaneous documents. Q2 2023
2024-03-06 English
LIFE: Poster presentations at ATTD 2024 in Firenze
Report Publication Announcement Classification · 1% confidence The document is a short announcement detailing that Lifecare will present three poster presentations at the ATTD 2024 conference in Firenze regarding their Sencell sensor technology and interference testing results on other CGM devices. It includes background information about the conference and the company, and crucially, it lists attachments which are links to the actual presentation materials (PDFs). Since the document itself is an announcement about the publication/presentation of specific materials (posters/presentations) rather than the full report, financial filing, or transcript, it best fits the category for announcing the release of company information or presentations. Given the context of presenting research/technology at a conference, it is closely related to Investor Presentation (IP) or a general Regulatory Filing (RNS). However, because it explicitly announces the presentation of specific materials (posters) and provides links to those materials, it functions as a Report Publication Announcement (RPA) or a general announcement of new information. Since 'IP' is for detailed investor presentations and this is about conference posters, 'RPA' (Report Publication Announcement) or 'RNS' (Regulatory Filings) are the closest fits. Given the nature of announcing specific, non-mandated research dissemination, RNS is a strong fallback, but RPA covers the act of announcing the availability of published material. I will classify this as RNS as it is a general announcement of company activity/research dissemination that doesn't fit the core financial report types, adhering to the 'Menu vs Meal' rule by identifying it as an announcement, not the presentation itself.
2024-03-06 English
LIFE: Poster presentations at ATTD 2024 in Firenze
Regulatory Filings Classification · 1% confidence The document is a short announcement from Lifecare AS regarding their participation and poster presentations at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024). It details the topics of the presentations (Sencell sensor pilot study, dynamic interference testing on CGM devices) and provides company background. This is not a formal regulatory filing (like 10-K, IR, ER), nor is it a transcript, management discussion, or financial supplement. It is an announcement about company activities and scientific dissemination, which fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate update, or potentially an Investor Presentation (IP) if it were the presentation itself, but since it's an announcement *about* presentations, RNS is the most appropriate fallback for non-standard corporate news releases.
2024-03-06 English
LIFE: Placing purchase order for cleanroom
Regulatory Filings Classification · 1% confidence The document is a short press release dated March 5, 2024, announcing a specific operational update: placing a purchase order for a cleanroom as a step towards automated pilot production. It mentions referencing a 'semi-annual report' and 'investor communication' but does not contain the full financial details of a report (like 10-K or IR). It is an announcement of a specific corporate action/update, not a formal regulatory filing like a Director's Dealing (DIRS), Major Shareholding (MRQ), or Dividend (DIV). Given its nature as a specific, non-standard operational update that is not a full financial report, earnings release (ER), or capital event (CAP), it fits best under the general regulatory announcement category, which is RNS, as it is submitted pursuant to securities trading acts and MAR Article 19.
2024-03-05 English
LIFE: Placing purchase order for cleanroom
Share Issue/Capital Change Classification · 1% confidence The document is a short press release dated March 5, 2024, announcing a specific operational event: placing a purchase order for a cleanroom as part of the preparation for automated pilot production. It references previous communications (semi-annual report) and mentions regulatory disclosure requirements ("Securities Trading Act § 5-12 and MAR Article 19 no. 3"). This type of announcement, detailing a specific operational step or material event that doesn't fit neatly into earnings, capital changes, or director dealings, is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the purchase was framed as a major financing event, but here it seems like a standard operational update. Given the content is a brief update on production readiness and not a comprehensive financial report (like 10-K or IR) or a specific corporate action like a dividend or share issue, RNS (Regulatory Filings) serves as the most appropriate general category for this type of market-sensitive operational disclosure, especially since it cites MAR disclosure rules.
2024-03-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.